Ranolazine - A nicely timed new medical therapy for stable angina

International Journal of Clinical Practice

Volumn 61, Issue 7, 2007, Pages 1063-

  Jackson, Graham ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RANOLAZINE; TRIMETAZIDINE;

ACUTE CORONARY SYNDROME; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SURGERY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG TOLERABILITY; EDITORIAL; ELECTROCARDIOGRAM; HUMAN; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; QT INTERVAL; REVASCULARIZATION; STABLE ANGINA PECTORIS; SYNCOPE; UNITED KINGDOM; WESTERN HEMISPHERE;

ACETANILIDES; ANGINA PECTORIS; ENZYME INHIBITORS; HUMANS; PIPERAZINES;

EID: 34250628123     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01457.x     Document Type: Editorial

References (7)

1. Jackson G. Stable and also unstable coronary disease - COURAGE and the importance of optimal medical therapy. Int J Clin Pract 2007 61: 883.
2. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007 356: 1503 16.
3. Hueb W, Lopes NH, Gersh BJ et al. Five year follow-up of the Medicine, Angioplasty or Surgery Study (MASS II): a randomised controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2007 115: 1082 89.
4. Jackson G. A metabolic approach to the management of ischemic heart disease: clinical benefits with trimetazidine. Am J Cardiovasc Drugs 2003 3 (Suppl. 1 27 33.
5. Pham DQ, Mehta M. Ranolazine: a novel agent that improves dysfunctional sodium channels. Int J Clin Pract 2007 61: 864 872.
6. Morrow DA, Scirica BM, Karwatowska-Prokopczuk E et al. Effects of ranolazine on recurrent cardiovascular events in patients with non-ST elevation acute coronary syndromes: the MERLIN-TIMI 36 Randomised Trial. JAMA 2007 297: 1775 1783.
7. Koren MJ, Crager MR, Sweeney M. Long-term safety of a novel antianginal agent in patients with severe chronic stable angina. The Ranolazine Open Label Experience (ROLE). J Am Coll Cardiol 2007 49: 1027 34.